Bio Impact Capital LLC Provention Bio, Inc. Transaction History

Bio Impact Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$6.7 - $24.21 $1.84 Million - $6.67 Million	275,326 Added 30.64%	1,173,809 $28.3 Million
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $714,788 - $1.67 Million	158,139 Added 21.36%	898,483 $9.5 Million
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.62 $507,327 - $831,248	147,909 Added 24.97%	740,344 $3.33 Million
Q2 2022 Aug 11, 2022	BUY	$3.65 - $7.3 $2.16 Million - $4.32 Million	592,435 New	592,435 $2.37 Million

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bio Impact Capital LLC with notifications on news.